Neuland Laboratories

Expert analytical method development and validation for APIs and peptides, including impurity profiling, stability studies, and regulatory compliance.

Full spectrum CDMO capabilities for API manufacturing, partnering with US pharma & biotech from molecule development to commercialization.

Expert CDMO services for API design, manufacturing & compliance, helping US pharma & biotech achieve efficient, high-quality drug production.

Neuland applies complex chemistry expertise, including cyanation, hydrogenation, and chiral chemistry, to develop and manufacture challenging APIs.

Neuland Labs shares expert blogs on CDMO trends, API manufacturing, peptide development, and sustainable pharmaceutical supply chains for global clients.

Neuland’s insights hub features stories, brochures, case studies, events, and news on API development and CDMO manufacturing worldwide.

Definitions of key pharmaceutical and biotech terms covering API manufacturing, CDMO services, peptide synthesis, and regulatory terminology.

Neuland Labs participates in pharmaceutical conferences, trade shows, webinars, and industry events worldwide.

Saharsh Davuluri assumes the role of CEO & MD at Neuland, leading its next phase of CDMO growth, strengthening capabilities in complex APIs, peptides, and global partnerships.

Booth No #1218

Neuland unveils its new vision and values statements, reinforcing commitment to innovation, integrity and sustainability in driving business and growth.

Neuland Labs received the 2013 CMO Leadership Award for Regulatory Excellence for its commitment to quality and compliance in contract manufacturing.

Neuland Labs introduces its leadership team, which drives innovation in API manufacturing, CDMO operations, and pharmaceutical partnerships.

Trusted API CDMO with 40+ years of expertise, serving 500+ pharma and biotech customers across the US, Europe, and Japan.

Neuland's climate strategy addresses energy efficiency, water stewardship, and waste reduction, anchored by science-based targets validated by the SBTi.

Neuland operates a facility network in Hyderabad, including an R&D center, three API manufacturing units, and a peptide plant, all under global cGMP oversight.

Investor hub for Neuland Laboratories (NSE: NEULANDLAB) — financials, governance, presentations, and shareholder services in one place.

Neuland Labs offers API development, custom manufacturing, peptide synthesis, and CDMO partnerships worldwide.